$CRL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Get notifications about new insider transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 63 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2020 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Option Exercise | A | 164.30 | 573 | 94,144 | 573 | |
| Mar 04 2020 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Option Exercise | A | 164.30 | 573 | 94,144 | 573 | |
| Mar 04 2020 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Grant | A | 0.00 | 124 | 0 | 124 | 0 to 124 |
| Mar 04 2020 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Grant | A | 0.00 | 124 | 0 | 124 | 0 to 124 |
| Feb 28 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Option Exercise | M | 70.29 | 3,140 | 220,711 | 0 | |
| Feb 28 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Option Exercise | M | 43.39 | 4,030 | 174,862 | 0 | |
| Feb 28 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 160.89 | 2,464 | 396,437 | 39,541 | 42 K to 39.5 K (-5.87 %) |
| Feb 28 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Buy | M | 70.29 | 3,140 | 220,711 | 42,005 | 38.9 K to 42 K (+8.08 %) |
| Feb 28 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Buy | M | 43.39 | 4,030 | 174,862 | 38,865 | 34.8 K to 38.9 K (+11.57 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 73.70 | 4,188 | 308,656 | 0 | |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 164.20 | 738 | 121,176 | 20,475 | 21.2 K to 20.5 K (-3.48 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 163.38 | 657 | 107,339 | 21,213 | 21.9 K to 21.2 K (-3.00 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 162.27 | 1,027 | 166,654 | 21,870 | 22.9 K to 21.9 K (-4.49 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 161.58 | 898 | 145,095 | 22,897 | 23.8 K to 22.9 K (-3.77 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 160.45 | 868 | 139,271 | 23,795 | 24.7 K to 23.8 K (-3.52 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 73.70 | 4,188 | 308,656 | 24,663 | 20.5 K to 24.7 K (+20.45 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 73.70 | 25,124 | 1,851,639 | 0 | |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 164.13 | 4,896 | 803,577 | 286,775 | 291.7 K to 286.8 K (-1.68 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 163.31 | 4,198 | 685,563 | 291,671 | 295.9 K to 291.7 K (-1.42 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 162.21 | 6,621 | 1,073,992 | 295,869 | 302.5 K to 295.9 K (-2.19 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 161.40 | 4,098 | 661,406 | 302,490 | 306.6 K to 302.5 K (-1.34 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 160.40 | 5,311 | 851,874 | 306,588 | 311.9 K to 306.6 K (-1.70 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 73.70 | 25,124 | 1,851,639 | 311,899 | 286.8 K to 311.9 K (+8.76 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 73.70 | 4,188 | 308,656 | 0 | |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 164.20 | 738 | 121,176 | 20,475 | 21.2 K to 20.5 K (-3.48 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 163.38 | 657 | 107,339 | 21,213 | 21.9 K to 21.2 K (-3.00 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 162.27 | 1,027 | 166,654 | 21,870 | 22.9 K to 21.9 K (-4.49 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 161.58 | 898 | 145,095 | 22,897 | 23.8 K to 22.9 K (-3.77 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 160.45 | 868 | 139,271 | 23,795 | 24.7 K to 23.8 K (-3.52 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 73.70 | 4,188 | 308,656 | 24,663 | 20.5 K to 24.7 K (+20.45 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 73.70 | 25,124 | 1,851,639 | 0 | |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 164.13 | 4,896 | 803,577 | 286,775 | 291.7 K to 286.8 K (-1.68 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 163.31 | 4,198 | 685,563 | 291,671 | 295.9 K to 291.7 K (-1.42 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 162.21 | 6,621 | 1,073,992 | 295,869 | 302.5 K to 295.9 K (-2.19 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 161.40 | 4,098 | 661,406 | 302,490 | 306.6 K to 302.5 K (-1.34 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 160.40 | 5,311 | 851,874 | 306,588 | 311.9 K to 306.6 K (-1.70 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 73.70 | 25,124 | 1,851,639 | 311,899 | 286.8 K to 311.9 K (+8.76 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 162.46 | 273 | 44,352 | 17,734 | 18 K to 17.7 K (-1.52 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 162.46 | 2,271 | 368,947 | 286,775 | 289 K to 286.8 K (-0.79 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 162.46 | 152 | 24,694 | 22,617 | 22.8 K to 22.6 K (-0.67 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Payment of Exercise | F | 162.46 | 727 | 118,108 | 223,921 | 224.6 K to 223.9 K (-0.32 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 162.46 | 303 | 49,225 | 19,055 | 19.4 K to 19.1 K (-1.57 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 162.46 | 379 | 61,572 | 20,475 | 20.9 K to 20.5 K (-1.82 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 109.34 | 20,295 | 2,219,055 | 40,591 | |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 88.05 | 24,008 | 2,113,904 | 24,009 | |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 167.83 | 2,250 | 377,618 | 2,250 | 4.5 K to 2.3 K (-50.00 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 167.83 | 750 | 125,873 | 750 | 1.5 K to 750 (-50.00 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 168.34 | 1,445 | 243,249 | 289,046 | 290.5 K to 289 K (-0.50 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 167.44 | 6,156 | 1,030,761 | 290,491 | 296.6 K to 290.5 K (-2.08 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 166.52 | 36,702 | 6,111,423 | 296,647 | 333.3 K to 296.6 K (-11.01 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 109.34 | 20,295 | 2,219,055 | 333,349 | 313.1 K to 333.3 K (+6.48 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 88.05 | 24,008 | 2,113,904 | 313,054 | 289 K to 313.1 K (+8.31 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 109.34 | 3,846 | 420,522 | 7,691 | |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 88.05 | 4,365 | 384,338 | 4,366 | |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 168.37 | 351 | 59,097 | 20,854 | 21.2 K to 20.9 K (-1.66 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 167.49 | 985 | 164,982 | 21,205 | 22.2 K to 21.2 K (-4.44 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 166.53 | 6,875 | 1,144,874 | 22,190 | 29.1 K to 22.2 K (-23.65 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 109.34 | 3,846 | 420,522 | 29,065 | 25.2 K to 29.1 K (+15.25 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 88.05 | 4,365 | 384,338 | 25,219 | 20.9 K to 25.2 K (+20.93 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 173.64 | 2,210 | 383,744 | 289,046 | 291.3 K to 289 K (-0.76 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 173.64 | 1,994 | 346,238 | 291,256 | 293.3 K to 291.3 K (-0.68 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 173.64 | 1,814 | 314,983 | 293,250 | 295.1 K to 293.3 K (-0.61 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 3,000 | 0 | 295,064 | 298.1 K to 295.1 K (-1.01 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 173.64 | 322 | 55,912 | 18,007 | 18.3 K to 18 K (-1.76 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 173.64 | 315 | 54,697 | 18,329 | 18.6 K to 18.3 K (-1.69 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 173.64 | 287 | 49,835 | 18,644 | 18.9 K to 18.6 K (-1.52 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 173.64 | 322 | 55,912 | 22,769 | 23.1 K to 22.8 K (-1.39 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 173.64 | 315 | 54,697 | 23,091 | 23.4 K to 23.1 K (-1.35 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 173.64 | 308 | 53,481 | 23,406 | 23.7 K to 23.4 K (-1.30 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 402 | 69,803 | 20,854 | 21.3 K to 20.9 K (-1.89 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 378 | 65,636 | 21,256 | 21.6 K to 21.3 K (-1.75 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 344 | 59,732 | 21,634 | 22 K to 21.6 K (-1.57 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 173.64 | 322 | 55,912 | 19,358 | 19.7 K to 19.4 K (-1.64 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 173.64 | 315 | 54,697 | 19,680 | 20 K to 19.7 K (-1.58 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 173.64 | 317 | 55,044 | 19,995 | 20.3 K to 20 K (-1.56 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 173.64 | 56 | 9,724 | 1,992 | 2 K to 2 K (-2.73 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 173.64 | 51 | 8,856 | 2,048 | 2.1 K to 2 K (-2.43 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Payment of Exercise | F | 173.64 | 710 | 123,284 | 224,648 | 225.4 K to 224.6 K (-0.32 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Payment of Exercise | F | 173.64 | 862 | 149,678 | 225,358 | 226.2 K to 225.4 K (-0.38 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Payment of Exercise | F | 173.64 | 770 | 133,703 | 226,220 | 227 K to 226.2 K (-0.34 %) |
| Feb 19 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Option Exercise | M | 70.29 | 3,140 | 220,711 | 0 | |
| Feb 19 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Option Exercise | M | 43.39 | 4,030 | 174,862 | 0 | |
| Feb 19 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Sell | S | 176.07 | 7,170 | 1,262,430 | 27,037 | 34.2 K to 27 K (-20.96 %) |
| Feb 19 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Buy | M | 70.29 | 3,140 | 220,711 | 34,207 | 31.1 K to 34.2 K (+10.11 %) |
| Feb 19 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Buy | M | 43.39 | 4,030 | 174,862 | 31,067 | 27 K to 31.1 K (+14.91 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 52.29 | 3,530 | 184,584 | 0 | |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 174.29 | 3,530 | 615,258 | 29,367 | 32.9 K to 29.4 K (-10.73 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 52.29 | 3,530 | 184,584 | 32,897 | 29.4 K to 32.9 K (+12.02 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 70.29 | 3,140 | 220,711 | 0 | |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 43.39 | 4,030 | 174,862 | 0 | |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 172.02 | 7,170 | 1,233,391 | 29,367 | 36.5 K to 29.4 K (-19.62 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 70.29 | 3,140 | 220,711 | 36,537 | 33.4 K to 36.5 K (+9.40 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 43.39 | 4,030 | 174,862 | 33,397 | 29.4 K to 33.4 K (+13.72 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 172.33 | 600 | 103,398 | 298,064 | 298.7 K to 298.1 K (-0.20 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 171.88 | 14,400 | 2,475,042 | 298,664 | 313.1 K to 298.7 K (-4.60 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Option Exercise | M | 70.29 | 3,140 | 220,711 | 0 | |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Option Exercise | M | 43.39 | 4,030 | 174,862 | 0 | |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Sell | S | 170.41 | 7,170 | 1,221,819 | 27,875 | 35 K to 27.9 K (-20.46 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Buy | M | 70.29 | 3,140 | 220,711 | 35,045 | 31.9 K to 35 K (+9.84 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Buy | M | 43.39 | 4,030 | 174,862 | 31,905 | 27.9 K to 31.9 K (+14.46 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Sell | S | 172.11 | 6,901 | 1,187,699 | 18,931 | 25.8 K to 18.9 K (-26.71 %) |
| Feb 14 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 172.05 | 900 | 154,845 | 23,714 | 24.6 K to 23.7 K (-3.66 %) |
| Feb 13 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 170.29 | 4,500 | 766,319 | 21,978 | 26.5 K to 22 K (-17.00 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 159.07 | 3,846 | 611,783 | 20,312 | 24.2 K to 20.3 K (-15.92 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Grant | A | 0.00 | 10,745 | 0 | 24,158 | 13.4 K to 24.2 K (+80.11 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 159.07 | 5,031 | 800,281 | 26,478 | 31.5 K to 26.5 K (-15.97 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 13,431 | 0 | 31,509 | 18.1 K to 31.5 K (+74.29 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Payment of Exercise | F | 159.07 | 9,592 | 1,525,799 | 226,990 | 236.6 K to 227 K (-4.05 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Grant | A | 0.00 | 23,728 | 0 | 236,582 | 212.9 K to 236.6 K (+11.15 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 159.07 | 3,846 | 611,783 | 24,614 | 28.5 K to 24.6 K (-13.51 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Grant | A | 0.00 | 10,745 | 0 | 28,460 | 17.7 K to 28.5 K (+60.65 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 159.07 | 31,824 | 5,062,244 | 313,064 | 344.9 K to 313.1 K (-9.23 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Grant | A | 0.00 | 73,873 | 0 | 344,888 | 271 K to 344.9 K (+27.26 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 3,500 | 0 | 271,015 | 274.5 K to 271 K (-1.27 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 159.07 | 3,844 | 611,465 | 25,832 | 29.7 K to 25.8 K (-12.95 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Grant | A | 0.00 | 10,745 | 0 | 29,676 | 18.9 K to 29.7 K (+56.76 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Option Exercise | M | 76.67 | 24,660 | 1,890,682 | 0 | |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.90 | 237 | 34,578 | 212,854 | 213.1 K to 212.9 K (-0.11 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.47 | 10 | 1,455 | 213,091 | 213.1 K to 213.1 K (0.00 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.46 | 103 | 14,982 | 213,101 | 213.2 K to 213.1 K (-0.05 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.26 | 23 | 3,341 | 213,204 | 213.2 K to 213.2 K (-0.01 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.23 | 77 | 11,183 | 213,227 | 213.3 K to 213.2 K (-0.04 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.22 | 400 | 58,088 | 213,304 | 213.7 K to 213.3 K (-0.19 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.17 | 64 | 9,291 | 213,704 | 213.8 K to 213.7 K (-0.03 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.16 | 58 | 8,419 | 213,768 | 213.8 K to 213.8 K (-0.03 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.15 | 52 | 7,548 | 213,826 | 213.9 K to 213.8 K (-0.02 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.14 | 221 | 32,076 | 213,878 | 214.1 K to 213.9 K (-0.10 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.13 | 553 | 80,257 | 214,099 | 214.7 K to 214.1 K (-0.26 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 145.00 | 3,113 | 451,385 | 214,652 | 217.8 K to 214.7 K (-1.43 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.71 | 58 | 8,393 | 217,765 | 217.8 K to 217.8 K (-0.03 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.70 | 53 | 7,669 | 217,823 | 217.9 K to 217.8 K (-0.02 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.69 | 157 | 22,716 | 217,876 | 218 K to 217.9 K (-0.07 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.68 | 100 | 14,468 | 218,033 | 218.1 K to 218 K (-0.05 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.67 | 532 | 76,964 | 218,133 | 218.7 K to 218.1 K (-0.24 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.52 | 101 | 14,597 | 218,665 | 218.8 K to 218.7 K (-0.05 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.41 | 214 | 30,904 | 218,766 | 219 K to 218.8 K (-0.10 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.40 | 75 | 10,830 | 218,980 | 219.1 K to 219 K (-0.03 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.25 | 200 | 28,850 | 219,055 | 219.3 K to 219.1 K (-0.09 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.24 | 1,100 | 158,664 | 219,255 | 220.4 K to 219.3 K (-0.50 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.23 | 2,400 | 346,152 | 220,355 | 222.8 K to 220.4 K (-1.08 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.22 | 1,400 | 201,908 | 222,755 | 224.2 K to 222.8 K (-0.62 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.21 | 700 | 100,947 | 224,155 | 224.9 K to 224.2 K (-0.31 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 144.00 | 957 | 137,808 | 224,855 | 225.8 K to 224.9 K (-0.42 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 143.82 | 543 | 78,094 | 225,812 | 226.4 K to 225.8 K (-0.24 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 143.81 | 10,959 | 1,576,014 | 226,355 | 237.3 K to 226.4 K (-4.62 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Sell | S | 143.80 | 200 | 28,760 | 237,314 | 237.5 K to 237.3 K (-0.08 %) |
| Dec 11 2019 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Buy | M | 76.67 | 24,660 | 1,890,682 | 237,514 | 212.9 K to 237.5 K (+11.59 %) |
| Dec 10 2019 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 146.79 | 18 | 2,642 | 17,715 | 17.7 K to 17.7 K (-0.10 %) |
| Dec 10 2019 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 146.61 | 92 | 13,488 | 17,733 | 17.8 K to 17.7 K (-0.52 %) |
| Dec 10 2019 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 146.51 | 100 | 14,651 | 17,825 | 17.9 K to 17.8 K (-0.56 %) |